national university cancer institute singapore

This New Antibody Drug Could Slow Down Cancer

PRL3-zumab, an antibody drug targeting a protein in cancer cells, has shown safety and efficacy in clinical trials.

Experts Discuss Latest In Hematology Research At Suntec Singapore

Hematology experts gathered at Suntec Singapore from March 29-30, 2014 to discuss the latest in blood disorders research.